Schering Corporation / GlaxoSmithKline / III Melanoma / Skin Cancer Program University / Melanoma Committee Eastern Cooperative Oncology Group / Glaxosmithkline plc / /
Currency
pence / /
Event
FDA Phase / /
Facility
Chapel Hill Clinical Perspective / Medicine University of North Carolina / /
IndustryTerm
treatment of stage III melanoma / treatment for melanoma / /
MedicalCondition
torsades de pointes / III Melanoma / skin cancer / melanoma / original cancer / hypertension / cancer / disease / cardiac arrhythmias / severe depression / depression / advanced renal cell carcinoma / kidney cancer / /
MedicalTreatment
surgery / Adjuvant Therapy / /
Organization
office of Biostatistics / Division of Drug Oncology Products / office of Translational Science / Division of Biostatistics / Division of Biologic Oncology Products / University of North Carolina / Erasmus University Medical School The Netherlands / University of Pittsburgh / U.S. Food and Drug Administration / Oncologic Drugs Advisory Committee / M.P.H. Acting Committee / Center for Drug Evaluation and Research / /
Person
Patricia Keegan / Gary Lyman / M.D. Jean Grem / Paolo Paoletti / S. Gail Eckhardt / Charles Stimler / John Vierling / Robert Motzer / Mikkael Sekeres / Gregory Curt / M.D. Wyndham Wilson / Microscopic Nodal Metastasis Alexander Eggermont / Susan Arbuck / Diane Aronson / Ronald Richardson / Alexander Eggermont / Yu-Ling Chang / Margaret Tempero / M.D. Virginia Mason / Rafael Amado / Michael Link / Nicole Vesely / Cora Sternberg / Remarks Paolo Paoletti / Richard Pazdur / Kenneth McDonough / M.D. Patrick Loehrer / V. Ellen Maher / Mary Meyer / Genevieve Schechter / Charles Balch / Leonard Seeff / William Kelly / Ralph Freedman / Safety Antoine Yver / Bruce G. Redman / Yang-Min (Max) Ning / Mark Rothmann / Harry Long / / /
Position
Vice President Global Clinical Research Oncology / Principal Investigator / Designated Federal Official / SVP / Chairman / Department of Medical Oncology San Camillo and Forlanini Hospitals Summary / Federal Official / Professor of Surgery / Attending Physician Memorial Sloan Kettering Cancer Center / VP Medicines Development Leader / President / EORTC / Professor / Director / Acting Chair / Chair / Medical Officer / Representative / R.N. / MSc Executive Director Global Clinical Research Oncology Schering-Plough Research Institute Peg-IFN / Professor of Medicine / M.P.H. Acting Chair / /
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may